Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI, [2000-
- الموضوع:
- نبذة مختصرة :
Circulating monocytes are recruited in damaged tissues to generate macrophages that modulate disease progression. Colony-stimulating factor-1 (CSF-1) promotes the generation of monocyte-derived macrophages, which involves caspase activation. Here, we demonstrate that activated caspase-3 and caspase-7 are located to the vicinity of the mitochondria in CSF1-treated human monocytes. Active caspase-7 cleaves p47 PHOX at aspartate 34, which promotes the formation of the NADPH (nicotinamide adenine dinucleotide phosphate) oxidase complex NOX2 and the production of cytosolic superoxide anions. Monocyte response to CSF-1 is altered in patients with a chronic granulomatous disease, which are constitutively defective in NOX2. Both caspase-7 down-regulation and radical oxygen species scavenging decrease the migration of CSF-1-induced macrophages. Inhibition or deletion of caspases prevents the development of lung fibrosis in mice exposed to bleomycin. Altogether, a non-conventional pathway that involves caspases and activates NOX2 is involved in CSF1-driven monocyte differentiation and could be therapeutically targeted to modulate macrophage polarization in damaged tissues.
- References:
Annu Rev Pathol. 2020 Jan 24;15:123-147. (PMID: 31530089)
Physiol Rev. 2007 Jan;87(1):245-313. (PMID: 17237347)
Nat Med. 2013 Oct;19(10):1264-72. (PMID: 24056773)
Science. 2010 Nov 5;330(6005):841-5. (PMID: 20966214)
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. (PMID: 21997792)
Cell Death Differ. 2011 Jan;18(1):90-8. (PMID: 20523353)
Trends Immunol. 2019 Feb;40(2):98-112. (PMID: 30579704)
J Biol Chem. 2006 Jun 30;281(26):17779-88. (PMID: 16636047)
PLoS Genet. 2017 Feb 16;13(2):e1006438. (PMID: 28207763)
Blood. 2011 Oct 27;118(17):4694-704. (PMID: 21876121)
J Immunol. 2004 Sep 1;173(5):2976-84. (PMID: 15322156)
Int J Mol Sci. 2012;13(4):4807-4818. (PMID: 22606010)
Clin Sci (Lond). 2016 Apr 1;130(7):479-90. (PMID: 26888560)
Cell Death Dis. 2017 Jan 5;8(1):e2534. (PMID: 28055016)
Bioorg Med Chem Lett. 2017 May 15;27(10):2153-2160. (PMID: 28377059)
Dev Cell. 2017 Jun 19;41(6):665-673.e6. (PMID: 28602583)
J Pathol. 2004 Dec;204(5):594-604. (PMID: 15538737)
J Leukoc Biol. 2021 Jan;109(1):121-141. (PMID: 32531842)
Cell. 2010 Apr 2;141(1):39-51. (PMID: 20371344)
Science. 2016 May 20;352(6288):aad3018. (PMID: 27199435)
Cell Cycle. 2009 Jun 15;8(12):1853-9. (PMID: 19448405)
J Biol Chem. 2016 Sep 16;291(38):20030-41. (PMID: 27489105)
Respir Res. 2005 Jan 21;6:11. (PMID: 15663794)
Blood. 2007 Feb 15;109(4):1442-50. (PMID: 17047155)
Am J Respir Cell Mol Biol. 2014 Apr;50(4):825-37. (PMID: 24325577)
Exp Mol Med. 2009 Apr 30;41(4):217-25. (PMID: 19372727)
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8. (PMID: 24101477)
Mediators Inflamm. 2013;2013:769214. (PMID: 23533311)
Cell Death Differ. 2017 Aug;24(8):1422-1430. (PMID: 28524858)
Cell. 2003 May 2;113(3):343-55. (PMID: 12732142)
J Clin Invest. 2006 Aug;116(8):2132-2141. (PMID: 16862213)
Biochim Biophys Acta Gen Subj. 2018 Jun;1862(6):1263-1275. (PMID: 29524539)
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a008656. (PMID: 23545416)
Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81. (PMID: 21680953)
J Biol Chem. 2005 Feb 18;280(7):5267-73. (PMID: 15611097)
Annu Rev Pathol. 2013 Jan 24;8:241-76. (PMID: 23092186)
Science. 1998 Nov 13;282(5392):1318-21. (PMID: 9812896)
Science. 2010 Feb 5;327(5966):656-61. (PMID: 20133564)
Mol Cell. 2017 Feb 16;65(4):715-729.e5. (PMID: 28212752)
J Immunol. 2017 Feb 1;198(3):1156-1163. (PMID: 28003378)
J Leukoc Biol. 2014 Jan;95(1):9-18. (PMID: 23964118)
Blood. 2012 Feb 9;119(6):1532-42. (PMID: 22160620)
Clin Sci (Lond). 2015 May 1;128(10):635-48. (PMID: 25760962)
Semin Immunol. 2014 Jun;26(3):246-52. (PMID: 24856110)
Nature. 2007 Jan 4;445(7123):102-5. (PMID: 17167422)
Dev Cell. 2016 Apr 4;37(1):15-33. (PMID: 27052834)
J Exp Med. 2012 Jun 4;209(6):1167-81. (PMID: 22565823)
Dev Cell. 2016 Apr 4;37(1):1-2. (PMID: 27046823)
JACS Au. 2021 Jul 08;1(8):1240-1256. (PMID: 34467362)
Dev Cell. 2016 Mar 7;36(5):498-510. (PMID: 26954545)
Curr Opin Struct Biol. 2013 Dec;23(6):812-9. (PMID: 24215810)
Nature. 2017 Mar 16;543(7645):428-432. (PMID: 28273064)
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17463-8. (PMID: 18981423)
N Engl J Med. 2015 Jul 30;373(5):428-37. (PMID: 26222558)
Mol Cell. 2007 Apr 27;26(2):301-10. (PMID: 17466630)
Blood. 2009 Oct 22;114(17):3633-41. (PMID: 19721010)
J Exp Med. 1998 Sep 7;188(5):919-30. (PMID: 9730893)
J Clin Invest. 2012 Mar;122(3):787-95. (PMID: 22378047)
J Cell Biol. 2015 May 11;209(3):453-66. (PMID: 25963822)
Blood. 2010 Dec 23;116(26):5795-802. (PMID: 20956805)
Blood. 2002 Dec 15;100(13):4446-53. (PMID: 12393560)
Nature. 2013 Apr 25;496(7446):445-55. (PMID: 23619691)
PLoS One. 2013;8(2):e54869. (PMID: 23383302)
Cancer Cell. 2014 Jun 16;25(6):846-59. (PMID: 24898549)
Cell Death Differ. 2017 Aug;24(8):1337-1347. (PMID: 28211870)
J Immunol. 2012 Jun 1;188(11):5752-65. (PMID: 22547697)
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8477-82. (PMID: 23650375)
Dev Cell. 2018 May 21;45(4):450-464.e3. (PMID: 29787709)
- Contributed Indexing:
Keywords: CSF1; NOX2; caspase; differentiation; lung fibrosis; macrophage
- الرقم المعرف:
81627-83-0 (Macrophage Colony-Stimulating Factor)
EC 3.4.22.- (Caspase 7)
EC 3.4.22.- (Caspases)
0 (Reactive Oxygen Species)
EC 1.6.3.- (NADPH Oxidases)
- الموضوع:
Date Created: 20230225 Date Completed: 20230228 Latest Revision: 20230301
- الموضوع:
20231215
- الرقم المعرف:
PMC9964254
- الرقم المعرف:
10.3390/ijms24044151
- الرقم المعرف:
36835566
No Comments.